H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Applied DNA Sciences (APDN - Research Report) today and set a price target of $8.00. The company's shares closed last Friday at $4.11.Chen covers the Healthcare sector, focusing on stocks such as Veru, Prophase Labs, and Stealth Biotherapeutics. According to TipRanks, Chen has an average return of -10.4% and a 33.15% success rate on recommended stocks. Applied DNA Sciences has an analyst consensus of Moderate Buy, with a price target consensus of $7.00, which is a 70.32% upside from current levels.
https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-its-buy-rating-for-applied-dna-sciences-apdn?utm_source=advfn.com&utm_medium=referral